04.16.14
St. Louis, Mo.-based Ulrich Medical USA Inc. has released its Tezo spine implants in the United States. The implants are indicated for multiple surgical approaches to lumbosacral interbody fusion, and were granted 510(k) U.S. Food and Drug Administration (FDA) clearance in June last year.
“We are experiencing a segmental market shift in the degenerative spine sector: A growing number of U.S. surgeons are switching back to interbody devices that are made from titanium materials versus polyetheretherketone (PEEK),” said vice president of sales and marketing Erika Laskey. “Titanium implants have a long and proven clinical history versus plastic implant technologies. And for many of our U.S. surgeons, the originally perceived imaging benefits of PEEK material implants are proving to be less important than the osseointegration qualities and overall implant strength and stability that titanium devices afford.”
The Tezo PLIF, TLIF and ALIF1 products reportedly maintain a porous structure on the inner surfaces of the implants that promotes integration of bone for enhanced fusion, as well as retroserrated toothing on the caudal and cranial surfaces of the implants that provide primary stability. The implants are available in various heights and angles, which allow for precise, intraoperative anatomical adaptation. Depending upon surgical technique preference, the Tezo devices are available from a 7 mm height to a 34 mm width in multiple lordotic angles.
“We believe that every patient deserves the best possible solution for their individual clinical needs, and there are benefits to both titanium and PEEK interbody technologies,” added Laskey. “As a result, we will continue to offer our wide range of Pezo interbody implants (PEEK) in addition to the new Tezo implants, which will give surgeons access to one of the broadest product portfolios in both PEEK and titanium interbody devices available in the U.S. spine market today.”
1. Posterior, transforaminal and anterior lumbar interbody fusion.
“We are experiencing a segmental market shift in the degenerative spine sector: A growing number of U.S. surgeons are switching back to interbody devices that are made from titanium materials versus polyetheretherketone (PEEK),” said vice president of sales and marketing Erika Laskey. “Titanium implants have a long and proven clinical history versus plastic implant technologies. And for many of our U.S. surgeons, the originally perceived imaging benefits of PEEK material implants are proving to be less important than the osseointegration qualities and overall implant strength and stability that titanium devices afford.”
The Tezo PLIF, TLIF and ALIF1 products reportedly maintain a porous structure on the inner surfaces of the implants that promotes integration of bone for enhanced fusion, as well as retroserrated toothing on the caudal and cranial surfaces of the implants that provide primary stability. The implants are available in various heights and angles, which allow for precise, intraoperative anatomical adaptation. Depending upon surgical technique preference, the Tezo devices are available from a 7 mm height to a 34 mm width in multiple lordotic angles.
“We believe that every patient deserves the best possible solution for their individual clinical needs, and there are benefits to both titanium and PEEK interbody technologies,” added Laskey. “As a result, we will continue to offer our wide range of Pezo interbody implants (PEEK) in addition to the new Tezo implants, which will give surgeons access to one of the broadest product portfolios in both PEEK and titanium interbody devices available in the U.S. spine market today.”
1. Posterior, transforaminal and anterior lumbar interbody fusion.